Characterization of Collaborative Practice Agreements (CPA) Held By Hematopoietic Cell Transplant (HCT) Pharmacists

Abstract

Background: With projected and current workforce shortages within the HCT field, a collaborative approach utilizing the unique skill set of the oncology-trained clinical pharmacist is crucial. Working within an agreed-upon protocol, pharmacists are able to expand patient care delivery, providing desired patient-centered outcomes via optimal medication therapy management. Methods: An electronic survey was developed by the Advocacy & Policy Working Committee of the American Society for Blood and Marrow Transplantation (ASBMT) Pharmacy Special Interest Group (SIG) and distributed using the internet-based survey tool esurveyspro.com to members of the BMT Pharmacists Google group and the ASBMT Pharmacy SIG email listservs. The primary objective was to assess the current state of CPAs already in place in the HCT setting. Additional objectives were to characterize these CPAs, describe commonly encountered barriers to implementing CPAs in this setting, and to describe perceived job-related benefits resulting from CPA implementation. Results: 48 responses representing 41 different institutions spanning 4 small (